Tags

Type your tag names separated by a space and hit enter

Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

15133890

Citation

MacLean, C H., et al. "Effects of Omega-3 Fatty Acids On Lipids and Glycemic Control in Type II Diabetes and the Metabolic Syndrome and On Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal Disease, Systemic Lupus Erythematosus, and Osteoporosis." Evidence Report/technology Assessment (Summary), 2004, pp. 1-4.
MacLean CH, Mojica WA, Morton SC, et al. Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis. Evid Rep Technol Assess (Summ). 2004.
MacLean, C. H., Mojica, W. A., Morton, S. C., Pencharz, J., Hasenfeld Garland, R., Tu, W., Newberry, S. J., Jungvig, L. K., Grossman, J., Khanna, P., Rhodes, S., & Shekelle, P. (2004). Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis. Evidence Report/technology Assessment (Summary), (89), 1-4.
MacLean CH, et al. Effects of Omega-3 Fatty Acids On Lipids and Glycemic Control in Type II Diabetes and the Metabolic Syndrome and On Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal Disease, Systemic Lupus Erythematosus, and Osteoporosis. Evid Rep Technol Assess (Summ). 2004;(89)1-4. PubMed PMID: 15133890.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis. AU - MacLean,C H, AU - Mojica,W A, AU - Morton,S C, AU - Pencharz,J, AU - Hasenfeld Garland,R, AU - Tu,W, AU - Newberry,S J, AU - Jungvig,L K, AU - Grossman,J, AU - Khanna,P, AU - Rhodes,S, AU - Shekelle,P, PY - 2004/5/12/pubmed PY - 2004/5/21/medline PY - 2004/5/12/entrez SP - 1 EP - 4 JF - Evidence report/technology assessment (Summary) JO - Evid Rep Technol Assess (Summ) IS - 89 SN - 1530-440X UR - https://www.unboundmedicine.com/medline/citation/15133890/Effects_of_omega_3_fatty_acids_on_lipids_and_glycemic_control_in_type_II_diabetes_and_the_metabolic_syndrome_and_on_inflammatory_bowel_disease_rheumatoid_arthritis_renal_disease_systemic_lupus_erythematosus_and_osteoporosis_ L2 - https://www.ncbi.nlm.nih.gov/books/NBK37146 DB - PRIME DP - Unbound Medicine ER -